New Frontiers in Women's Health, Ovarian Health & Longevity: Daisy Robinton - NextMed Health

Ovarian Health is intimately related to health, wellbeing and healthspan in women.

Ovaries age at 2X the rate of the human body, and fertility declines at mid-life. The hormonal changes associated with menopause speed up cellular aging by 6%.

Daisy Robinton, PhD, is CEO and co-founder of Aviva Therapeutics (https://www.ovivatx.com).

Oviva is studying the use of Anti-Mullarian Hormone (AMH) to regulate the pace of ovarian reserve depletion with the goal of extending women's wellbeing and longevity. More on

Daisy Robinton: https://www.nextmed.health/bio-daisyrobinton

Filmed at NextMed Health 2023: http://NextMed.Health

NextMed Health is a community and platform exploring the cutting edge of technology, health and biomedicine.

Join us at http://NextMed.Health/join

Previous

Quantified Health: From Big Data to Insights. Stanford's Michael Snyder at NextMed Health

Next

Paul Stamets on the Future of Psychedelics, Mycology & Medicine